A long-term, open-label extension study to investigate the long-term safety of alogliptin in subjects with type 2 diabetes

被引：0
|
作者：
Smith, N. [1 ]
Pratley, R. [2 ]
Wilson, C. [1 ]
Mekki, Q. [1 ]
机构：
[1] Takeda Global Res & Dev Ctr Inc, Deerfield, IL USA
[2] Florida Hosp, Translat Res Inst Diabet & Metab, Orlando, FL USA
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
780
引用
收藏
页码：S357 / S358
页数：2
相关论文
共 50 条
  • [21] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Banerji, A.
    Hao, J.
    Yu, M.
    Bernstein, J.
    Johnston, D.
    Riedl, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
  • [22] Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study
    Correll, Christoph U.
    Cucchiaro, Josephine
    Silva, Robert
    Hsu, Jay
    Pikalov, Andrei
    Loebel, Antony
    [J]. CNS SPECTRUMS, 2016, 21 (05) : 393 - 402
  • [23] Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia
    Chambers, Mark S.
    Jones, Christopher Uwe
    Biel, Merrill A.
    Weber, Randal S.
    Hodge, Kenneth M.
    Chen, Y.
    Holland, John M.
    Ship, Jonathan A.
    Vitti, Robert
    Armstrong, Ingrid
    Garden, Adam S.
    Haddad, Robert
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (05): : 1369 - 1376
  • [24] A long-term open-label safety study of galcanezumab in Japanese patients with migraine
    Hirata, Koichi
    Takeshima, Takao
    Sakai, Fumihiko
    Tatsuoka, Yoshihisa
    Suzuki, Norihiro
    Igarashi, Hisaka
    Nakamura, Tomomi
    Ozeki, Akichika
    Yamazaki, Hiroyoshi
    Skljarevski, Vladimir
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 721 - 733
  • [25] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [26] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
    Wroe, S
    Brodie, MJ
    [J]. EPILEPSIA, 2005, 46 : 118 - 118
  • [27] ELAMIPRETIDE IN THE MMPOWER-2 OPEN-LABEL EXTENSION TRIAL (OLE): LONG-TERM SAFETY AND TOLERABILITY
    Karaa, Amel
    Haas, Richard
    Goldstein, Amy
    Vockley, Gerard
    Cohen, Bruce
    [J]. MUSCLE & NERVE, 2018, 58 : S34 - S34
  • [28] Open-label, long-term safety study of zonisamide administered to children with epilepsy
    Shinnar, S
    Pellock, JM
    Conry, JA
    [J]. NEUROLOGY, 2006, 66 (05) : A37 - A37
  • [29] Effect of brexpiprazole on long-term remission in adults with schizophrenia: results of an open-label, long-term study
    Baker, R.
    Jin, N.
    Weiller, E.
    Weiss, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S952 - S952
  • [30] A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia
    Naoki Kashihara
    Yoshimitsu Yamasaki
    Takeshi Osonoi
    Hiromasa Harada
    Yugo Shibagaki
    June Zhao
    Hyosung Kim
    Toshitaka Yajima
    Nobuaki Sarai
    [J]. Clinical and Experimental Nephrology, 2021, 25 : 140 - 149
12345